Posted in Other Pulmonary fibrosis drug developer Avalyn files IPO April 9, 2026 Pharmaphorum Avalyn Pharma hops on the IPO train, filing to list on the Nasdaq and raise funds for late-stage trials of its inhaled pulmonary fibrosis therapies. OtherRespiratoryRead full story